SG/PUT/MEDTRONIC/70/0.1/21.03.25 Share Price

Warrant

DE000SU6QZQ9

Market Closed - Boerse Frankfurt Warrants 01:20:41 06/07/2024 am IST
0.24 EUR -7.69% Intraday chart for SG/PUT/MEDTRONIC/70/0.1/21.03.25
Current month+8.70%
1 month+25.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/24/05 0.25 -3.85%
04/24/04 0.26 0.00%
03/24/03 0.26 0.00%
02/24/02 0.26 +4.00%
01/24/01 0.25 +8.70%

Real-time Boerse Frankfurt Warrants

Last update July 06, 2024 at 01:20 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SU6QZQ
ISINDE000SU6QZQ9
Date issued 08/01/2024
Strike 70 $
Maturity 21/03/2025 (258 Days)
Parity 10 : 1
Emission price 0.35
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.36
Lowest since issue 0.16
Spread 0.01
Spread %3.85%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.61 USD
Average target price
94.02 USD
Spread / Average Target
+21.15%
Consensus